Related Experiment Videos
[Predictive factors for acute radiation pneumonitis].
1Service de pneumologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69317 Lyon cedex 04, France. dominique.arpin@chu-lyon.fr <dominique.arpin@chu-lyon.fr>
Revue De Pneumologie Clinique
|June 16, 2009
Summary
Acute radiation pneumonitis (ARP) risk in lung cancer patients is primarily linked to radiation factors, not patient or tumor characteristics. Research is exploring biological markers for individual susceptibility to thoracic radiotherapy toxicity.
Area of Science:
- Oncology
- Radiotherapy
- Pulmonology
Context:
- Thoracic irradiation is a key treatment for nonmetastatic primary lung cancer, especially locally advanced mediastinal disease.
- Acute radiation pneumonitis (ARP) is a significant treatment-limiting toxicity.
- Understanding ARP risk factors is crucial for optimizing lung cancer treatment.
Purpose:
- To review current knowledge on risk factors associated with developing acute radiation pneumonitis (ARP).
- To identify patient, tumor, and treatment-related factors influencing ARP incidence.
- To highlight validated predictive factors and emerging research areas for ARP.
Summary:
- ARP incidence in non-small cell lung cancer (NSCLC) patients undergoing conventional irradiation ranges from 7-10% for moderate forms to 1-3% for severe forms.
- Validated predictive factors for ARP are predominantly related to irradiation parameters, such as irradiated lung volumes and radiation dose.
- While patient age over 65 is debated, other patient/tumor factors show limited predictive value for ARP.
Impact:
- Identifies key irradiation parameters that predict ARP risk, aiding in treatment planning.
- Underscores the need for further research into individual susceptibility and biological markers (e.g., cytokines) for predicting ARP.
- Informs strategies to mitigate ARP, potentially improving patient outcomes in thoracic radiotherapy for lung cancer.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: